HUP0202180A3 - Method for treating chronic pain using mek inhibitors - Google Patents
Method for treating chronic pain using mek inhibitorsInfo
- Publication number
- HUP0202180A3 HUP0202180A3 HU0202180A HUP0202180A HUP0202180A3 HU P0202180 A3 HUP0202180 A3 HU P0202180A3 HU 0202180 A HU0202180 A HU 0202180A HU P0202180 A HUP0202180 A HU P0202180A HU P0202180 A3 HUP0202180 A3 HU P0202180A3
- Authority
- HU
- Hungary
- Prior art keywords
- chronic pain
- treating chronic
- mek inhibitors
- mek
- inhibitors
- Prior art date
Links
- 208000000094 Chronic Pain Diseases 0.000 title 1
- 208000002193 Pain Diseases 0.000 title 1
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14428099P | 1999-07-16 | 1999-07-16 | |
US14465999P | 1999-07-16 | 1999-07-16 | |
US14465899P | 1999-07-16 | 1999-07-16 | |
US14465599P | 1999-07-16 | 1999-07-16 | |
US14441999P | 1999-07-16 | 1999-07-16 | |
US14432099P | 1999-07-16 | 1999-07-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0202180A2 HUP0202180A2 (en) | 2002-10-28 |
HUP0202180A3 true HUP0202180A3 (en) | 2004-10-28 |
Family
ID=27558291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202180A HUP0202180A3 (en) | 1999-07-16 | 2000-07-05 | Method for treating chronic pain using mek inhibitors |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1202724B1 (en) |
JP (1) | JP2003504401A (en) |
KR (1) | KR20020016899A (en) |
CN (1) | CN1365277A (en) |
AT (1) | ATE250932T1 (en) |
AU (1) | AU5912500A (en) |
CA (1) | CA2378381A1 (en) |
DE (1) | DE60005688T2 (en) |
DK (1) | DK1202724T3 (en) |
ES (1) | ES2208364T3 (en) |
HK (1) | HK1047895A1 (en) |
HU (1) | HUP0202180A3 (en) |
IL (1) | IL147618A0 (en) |
PL (1) | PL352712A1 (en) |
PT (1) | PT1202724E (en) |
TR (1) | TR200200205T2 (en) |
WO (1) | WO2001005393A2 (en) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DOP2003000613A (en) | 2002-03-13 | 2003-09-30 | Array Biopharma Inc | DERIVATIVES OF BENCIMIDAZOL N3 RENTED AS MEK INHIBITORS (N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS) |
US7235537B2 (en) | 2002-03-13 | 2007-06-26 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
US7144907B2 (en) | 2003-09-03 | 2006-12-05 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
US7538120B2 (en) | 2003-09-03 | 2009-05-26 | Array Biopharma Inc. | Method of treating inflammatory diseases |
US7781595B2 (en) | 2003-09-22 | 2010-08-24 | S*Bio Pte Ltd. | Benzimidazole derivatives: preparation and pharmaceutical applications |
KR101013932B1 (en) | 2003-10-21 | 2011-02-14 | 워너-램버트 캄파니 엘엘씨 | Polymorphic form of n-[r-2,3-dihydroxy-propoxy]-3,4-difluoro-2-2-fluoro-4-iodophenylamino-benzamide |
EP1529951A1 (en) | 2003-11-06 | 2005-05-11 | Gaveco AB | A method and a system for disconnection of a fuel supply |
US7517994B2 (en) | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
US7772234B2 (en) | 2003-11-19 | 2010-08-10 | Array Biopharma Inc. | Bicyclic inhibitors of MEK and methods of use thereof |
US7732616B2 (en) | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
NZ590160A (en) | 2003-11-21 | 2012-07-27 | Array Biopharma Inc | AKT protein kinase inhibitors |
RS52670B (en) | 2004-06-11 | 2013-06-28 | Japan Tobacco Inc. | 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido[2,3-d]pyrimidine derivatives and related compounds for the treatment of cancer |
US7378423B2 (en) | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
KR20080019236A (en) | 2005-05-18 | 2008-03-03 | 어레이 바이오파마 인크. | Heterocyclic inhibitors of mek and methods of use thereof |
EP1904481B1 (en) | 2005-06-23 | 2016-02-17 | Array Biopharma, Inc. | Process for preparing benzimidazole compounds |
KR20130058072A (en) | 2005-10-07 | 2013-06-03 | 엑셀리시스, 인코포레이티드 | Azetidines as mek inhibitors for the treatment of proliferative diseases |
JP5116245B2 (en) * | 2006-03-24 | 2013-01-09 | 地方独立行政法人 東京都立産業技術研究センター | Calibration curve compound for use in automated analyzers |
US8063050B2 (en) | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
DE602007011628D1 (en) | 2006-07-06 | 2011-02-10 | Array Biopharma Inc | DIHYDROFUROPYRIMIDINES AS ACT PROTEIN KINASE INHIBITORS |
AU2007269052B2 (en) | 2006-07-06 | 2014-10-23 | Array Biopharma Inc. | Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors |
SI2054418T1 (en) | 2006-07-06 | 2012-02-29 | Array Biopharma Inc | Dihydrothieno pyrimidines as akt protein kinase inhibitors |
CN101605540A (en) | 2006-12-14 | 2009-12-16 | 埃克塞利希斯股份有限公司 | Use the method for mek inhibitor |
RU2486181C2 (en) | 2007-07-05 | 2013-06-27 | Эррэй Биофарма Инк. | Pyrimidyl cyclopentanes as akt/protein kinase inhibitors |
MX2009014013A (en) | 2007-07-05 | 2010-01-28 | Array Biopharma Inc | Pyrimidyl cyclopentanes as akt protein kinase inhibitors. |
US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
GB0723794D0 (en) | 2007-12-05 | 2008-01-16 | Lectus Therapeutics Ltd | Potassium ion channel modulators and uses thereof |
JP5346345B2 (en) | 2008-01-09 | 2013-11-20 | アレイ バイオファーマ、インコーポレイテッド | Hydroxylated pyrimidylcyclopentanes as AKT protein kinase inhibitors |
CA2711692A1 (en) | 2008-01-09 | 2009-07-16 | Array Biopharma Inc. | Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor |
EP2346818B1 (en) | 2008-11-10 | 2012-12-05 | Bayer Intellectual Property GmbH | Substituted sulphonamido phenoxybenzamides |
JP2013508320A (en) | 2009-10-21 | 2013-03-07 | バイエル・ファルマ・アクチェンゲゼルシャフト | Substituted halophenoxybenzamide derivatives |
CN102656142A (en) | 2009-10-21 | 2012-09-05 | 拜耳制药股份公司 | Substituted benzosulphonamides |
EP2491016A1 (en) | 2009-10-21 | 2012-08-29 | Bayer Pharma Aktiengesellschaft | Substituted benzosulphonamides |
JP5860045B2 (en) | 2010-07-09 | 2016-02-16 | ファイザー・リミテッドPfizer Limited | Compound |
US9045429B2 (en) | 2010-10-29 | 2015-06-02 | Bayer Intellectual Property Gmbh | Substituted phenoxypyridines |
EP2694073B1 (en) | 2011-04-01 | 2018-08-08 | Genentech, Inc. | Combinations of akt and mek inhibitors for treating cancer |
KR20140021646A (en) | 2011-04-01 | 2014-02-20 | 제넨테크, 인크. | Combinations of akt inhibitor compounds and erlotinib, and methods of use |
BR112015008113B1 (en) | 2012-10-12 | 2022-05-24 | Exelixis, Inc. | New process to prepare compounds for use in cancer treatment |
AR108257A1 (en) | 2016-05-02 | 2018-08-01 | Mei Pharma Inc | POLYMORPHIC FORMS OF 3- [2-BUTIL-1- (2-DIETILAMINO-ETIL) -1H-BENCIMIDAZOL-5-IL] -N-HYDROXY-ACRYLAMIDE AND USES OF THE SAME |
TN2018000385A1 (en) | 2016-05-20 | 2020-06-15 | Xenon Pharmaceuticals Inc | Benzenesulfonamide compounds and their use as therapeutic agents |
TN2019000175A1 (en) | 2016-12-09 | 2020-10-05 | Xenon Pharmaceuticals Inc | Benzenesulfonamide compounds and their use as therapeutic agents |
EP3590920A4 (en) * | 2017-03-02 | 2021-01-06 | Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 2-(substituted benzene matrix) aromatic formate fto inhibitor, preparation method therefor, and applications thereof |
MX2020013317A (en) | 2018-06-13 | 2021-04-13 | Xenon Pharmaceuticals Inc | Benzenesulfonamide compounds and their use as therapeutic agents. |
WO2020047312A1 (en) | 2018-08-31 | 2020-03-05 | Xenon Pharmaceuticals Inc. | Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors |
US10981905B2 (en) | 2018-08-31 | 2021-04-20 | Xenon Pharmaceuticals Inc. | Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents |
TW202340177A (en) | 2021-12-30 | 2023-10-16 | 美商拜歐米富士恩股份有限公司 | Pyrazine compounds as inhibitors of flt3 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL62219C (en) * | 1945-05-07 | |||
US5155110A (en) * | 1987-10-27 | 1992-10-13 | Warner-Lambert Company | Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition |
JP2773836B2 (en) * | 1988-07-12 | 1998-07-09 | 富士通株式会社 | Net extraction method for layout wiring for integrated circuits |
WO1998037881A1 (en) * | 1997-02-28 | 1998-09-03 | Warner Lambert Company | Method of treating or preventing septic shock by administering a mek inhibitor |
NZ501277A (en) * | 1997-07-01 | 2002-12-20 | Warner Lambert Co | -2(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors |
CA2348236A1 (en) * | 1999-01-13 | 2000-07-20 | Stephen Douglas Barrett | 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
ES2251851T3 (en) * | 1999-01-13 | 2006-05-01 | Warner-Lambert Company Llc | SULFOHYDROXAMIC AND SULFOHYDROXAMATE ACIDS AND ITS USE WITH MEK INHIBITORS. |
WO2000041505A2 (en) * | 1999-01-13 | 2000-07-20 | Warner-Lambert Company | Anthranilic acid derivatives |
JP2002534498A (en) * | 1999-01-13 | 2002-10-15 | ワーナー−ランバート・カンパニー | Benzenesulfonamide derivatives and their use as MEK inhibitors |
-
2000
- 2000-07-05 WO PCT/US2000/018348 patent/WO2001005393A2/en active IP Right Grant
- 2000-07-05 DK DK00945140T patent/DK1202724T3/en active
- 2000-07-05 DE DE60005688T patent/DE60005688T2/en not_active Expired - Fee Related
- 2000-07-05 HU HU0202180A patent/HUP0202180A3/en unknown
- 2000-07-05 CA CA002378381A patent/CA2378381A1/en not_active Abandoned
- 2000-07-05 AU AU59125/00A patent/AU5912500A/en not_active Abandoned
- 2000-07-05 ES ES00945140T patent/ES2208364T3/en not_active Expired - Lifetime
- 2000-07-05 EP EP00945140A patent/EP1202724B1/en not_active Expired - Lifetime
- 2000-07-05 PL PL00352712A patent/PL352712A1/en not_active Application Discontinuation
- 2000-07-05 KR KR1020027000632A patent/KR20020016899A/en not_active Application Discontinuation
- 2000-07-05 CN CN00809583A patent/CN1365277A/en active Pending
- 2000-07-05 IL IL14761800A patent/IL147618A0/en unknown
- 2000-07-05 PT PT00945140T patent/PT1202724E/en unknown
- 2000-07-05 AT AT00945140T patent/ATE250932T1/en not_active IP Right Cessation
- 2000-07-05 JP JP2001510450A patent/JP2003504401A/en active Pending
- 2000-07-05 TR TR2002/00205T patent/TR200200205T2/en unknown
-
2003
- 2003-01-07 HK HK03100164.7A patent/HK1047895A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE60005688T2 (en) | 2004-04-29 |
ES2208364T3 (en) | 2004-06-16 |
EP1202724B1 (en) | 2003-10-01 |
ATE250932T1 (en) | 2003-10-15 |
EP1202724A2 (en) | 2002-05-08 |
HK1047895A1 (en) | 2003-03-14 |
PL352712A1 (en) | 2003-09-08 |
CN1365277A (en) | 2002-08-21 |
JP2003504401A (en) | 2003-02-04 |
DE60005688D1 (en) | 2003-11-06 |
PT1202724E (en) | 2004-02-27 |
AU5912500A (en) | 2001-02-05 |
WO2001005393A2 (en) | 2001-01-25 |
IL147618A0 (en) | 2002-08-14 |
TR200200205T2 (en) | 2002-06-21 |
WO2001005393A3 (en) | 2001-05-10 |
HUP0202180A2 (en) | 2002-10-28 |
KR20020016899A (en) | 2002-03-06 |
DK1202724T3 (en) | 2004-01-26 |
CA2378381A1 (en) | 2001-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL147150A0 (en) | Method for treating chronic pain using mek inhibitors | |
HUP0202180A3 (en) | Method for treating chronic pain using mek inhibitors | |
IL147619A0 (en) | Method for treating chronic pain using mek inhibitors | |
IL147617A0 (en) | Method for treating chronic pain using mek inhibitors | |
EP1215963A4 (en) | Methods for treating neuropathic pain using hetreoarylmethanesulfonamides | |
IL126203A0 (en) | Method for treating pain | |
EP0906104A4 (en) | Method for treating pain | |
AU7963200A (en) | Improved method and apparatus for water treatment | |
AU2003218352A8 (en) | Method and system for treating tissue swelling | |
IL209352A0 (en) | 4-tetrazolyl-4phenylpiperidine derivatives for treating pain | |
AU9035498A (en) | Method for treating pain | |
AU1484202A (en) | Method for treating films | |
EP1139398A4 (en) | Method and apparatus for surface treatment | |
EP1446087A4 (en) | Method for treating non-neuropathic pain | |
IL164219A0 (en) | Method for treating and preventing hyparathyroidism | |
PL342076A1 (en) | Method of treating surfaces | |
AU7331300A (en) | Method for treating or preventing chronic prostatitis or chronic pelvic pain syndrome | |
EP1007046A4 (en) | Method for treatment of chronic bronchitis | |
IL126064A0 (en) | Method for treating pain | |
IL126063A0 (en) | Method for treating migraine pain | |
AU2002232606A1 (en) | Method and apparatus for treating breakthrough pain | |
AU9034798A (en) | Method for treating pain | |
GB0118883D0 (en) | Method for treating objects | |
GB0123898D0 (en) | Method for treating objects | |
EP1165852A4 (en) | Surface treatment method and treatment apparatus |